Overview Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris Status: Completed Trial end date: 2015-02-01 Target enrollment: Participant gender: Summary The objectives of this study are to evaluate the therapeutic equivalence and safety of Adapalene Gel 0.3% and Differin® (adapalene gel 0.3%). Phase: Phase 1 Details Lead Sponsor: Taro Pharmaceuticals USATreatments: Adapalene